Clinical Trials Logo

Diabetic Ulcer clinical trials

View clinical trials related to Diabetic Ulcer.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03286452 Completed - Pressure Ulcer Clinical Trials

The RESPOND Registry

RESPOND
Start date: February 21, 2017
Phase:
Study type: Observational [Patient Registry]

The RESPOND Registry is an observational study to assess the impact of PuraPly™ AM on the management of wounds in real world clinical settings; no experimental intervention is involved.

NCT ID: NCT03070938 Completed - Pressure Ulcer Clinical Trials

PuraPly™ Antimicrobial Wound Matrix and Wound Management

PuraPlyAM
Start date: November 2016
Phase: N/A
Study type: Observational

The PuraPly Antimicrobial Wound Matrix (PuraPly AM) case series is a prospective, observational study for patients who have received PuraPly AM which consists of a collagen sheet coated with polyhexamethylenbiguanide hydrochloride (PHMB) and is intended for the management of wounds; no experimental intervention is involved.

NCT ID: NCT00804414 Completed - Diabetes Clinical Trials

Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers

Start date: October 2008
Phase: Phase 3
Study type: Interventional

Evaluation of efficacy and safety of SBG vs placebo in the treatment of chronic diabetic foot ulcers.

NCT ID: NCT00638872 Completed - Diabetic Ulcer Clinical Trials

Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic Ulcers

Start date: October 2007
Phase: Phase 4
Study type: Interventional

The main objective of the study is to evaluate the efficacy of the polydeoxyribonucleotide in improving the healing of diabetic foot ulcers.